FORESITE 360 | Unsubscribe

- Physicians - Learn More
- About Us
- Blog
Parent's Guide
Sign In
Get started

Parents
Physicians
- Physicians - Learn More
About
- About Us
- Blog
Customer Care
- Contact Support
Policies

Get started

Unsubscribe

You’ve successfully unsubscribed from FORESITE 360 marketing emails.

Didn’t mean to unsubscribe?

Email

Parent's Guide eBook

Dive deeper into the world of newborn and infant genomics with our comprehensive eBook! Learn about the past, present and future of genetic screening and diagnostics. Simply enter your email below and embark on this enlightening journey. Questions? Reach us at info@foregenomics.com.

Email Address

First Name

Last Name

There was an error submitting the form. Please try again.

Thank you for your interest in learning more about how precision genomic medicine can benefit your child. Please see the below link to download your copy of "Parent's Guide to Newborn and Infant Genomics."

Download the eBook

FORESITE 360, by Fore Genomics, Inc. is the most comprehensive genetic testing service designed for healthy newborns, infants, and children to understand and manage their risk of disease. It offers disease screening for genetically linked and treatable diseases, medication screening to provide information on how a baby will respond to common medications, and on-demand access to genetic counseling. With FORESITE 360, parents receive yearly updates on their child's genomic insights, genetic counseling, and exclusive tailored content for their age group until the age of 18.

Customer Care

Contact Support

Policies

Shipping & Returns Privacy Policy

Accessibility Terms & Conditions

Disclaimer: These tests were developed and performance characteristics were determined by Fore Genomics’ service providers in collaboration with Fore Genomics, Inc. The US Food and Drug Administration (FDA) has not approved or cleared these tests; however, FDA clearance or approval is not currently required for clinical use. These tests are used for clinical purposes, and therefore validation was done as required under the requirements of the Clinical Laboratory Improvement Act (CLIA) of 1988. The results are not intended to be used as the sole means for clinical diagnosis or patient management decisions. The chance of a false-negative or a false-positive result due to laboratory error cannot be completely excluded. These results should not be regarded as investigational or for research.